Bank Of New York Mellon Corp Pulmonx Corp Transaction History

Bank Of New York Mellon Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.92 - $17.35 $756,051 - $2.67 Million	153,669 New	153,669 $1.3 Million
Q3 2022 Nov 14, 2022	BUY	$15.35 - $23.99 $219,796 - $343,512	14,319 Added 14.77%	111,273 $1.85 Million
Q2 2022 Aug 15, 2022	BUY	$14.0 - $27.95 $196,406 - $392,110	14,029 Added 16.92%	96,954 $1.43 Million
Q1 2022 May 11, 2022	BUY	$21.13 - $35.65 $549 - $926	26 Added 0.03%	82,925 $2.06 Million
Q4 2021 Feb 11, 2022	BUY	$29.72 - $45.1 $6,954 - $10,553	234 Added 0.28%	82,899 $2.66 Million
Q3 2021 Nov 12, 2021	BUY	$35.98 - $44.48 $241,281 - $298,282	6,706 Added 8.83%	82,665 $2.97 Million
Q2 2021 Aug 11, 2021	BUY	$37.61 - $48.0 $1.61 Million - $2.06 Million	42,848 Added 129.41%	75,959 $3.35 Million
Q1 2021 May 13, 2021	BUY	$44.0 - $67.54 $137,148 - $210,522	3,117 Added 10.39%	33,111 $1.51 Million
Q4 2020 Feb 09, 2021	BUY	$39.31 - $69.02 $1.18 Million - $2.07 Million	29,994 New	29,994 $2.07 Million

123

31M

300

204K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.